tradingkey.logo

tradingkey.logo
怜玢


Cosmos Health Inc

COSM
りォッチリストに远加
3.240USD
-79.800-96.10%
終倀 11-13 16:00ET
326.04M時䟡総額
損倱額盎近12ヶ月PER

Cosmos Health Incに぀いお 䌁業名

Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.

Cosmos Health Inc プロフィヌル


䌁業コヌドCOSM
䌚瀟名Cosmos Health Inc
䞊堎日May 19, 2010
最高経営責任者「CEO」Siokas (Grigorios)
埓業員数149
蚌刞皮類Ordinary Share
決算期末May 19
本瀟所圚地5 Agiou Georgiou, Pilea
郜垂THESSALONIKI
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜Greece
郵䟿番号554 38
電話番号303125363102
りェブサむトhttps://www.cosmosholdingsinc.com/
䌁業コヌドCOSM
䞊堎日May 19, 2010
最高経営責任者「CEO」Siokas (Grigorios)

Cosmos Health Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Grigorios Siokas
Mr. Grigorios Siokas
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
14.60M
+7.65%
Mr. Georgios (George) Terzis
Mr. Georgios (George) Terzis
Chief Financial Officer
Chief Financial Officer
2.56M
+12.81%
Mr. John James Hoidas
Mr. John James Hoidas
Independent Director
Independent Director
100.00K
+70.00%
Mr. Demetrios G. Demetriades
Mr. Demetrios G. Demetriades
Independent Director
Independent Director
65.00K
+46.15%
Dr. Anastasios (Tasos) Aslidis
Dr. Anastasios (Tasos) Aslidis
Independent Director
Independent Director
55.00K
-9.09%
Mr. Suhel Bhutawala
Mr. Suhel Bhutawala
Independent Director
Independent Director
50.00K
+10.00%
Mr. Nikos Bardakis
Mr. Nikos Bardakis
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Theodoros C. Karkantzos
Mr. Theodoros C. Karkantzos
Director
Director
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Grigorios Siokas
Mr. Grigorios Siokas
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
14.60M
+7.65%
Mr. Georgios (George) Terzis
Mr. Georgios (George) Terzis
Chief Financial Officer
Chief Financial Officer
2.56M
+12.81%
Mr. John James Hoidas
Mr. John James Hoidas
Independent Director
Independent Director
100.00K
+70.00%
Mr. Demetrios G. Demetriades
Mr. Demetrios G. Demetriades
Independent Director
Independent Director
65.00K
+46.15%
Dr. Anastasios (Tasos) Aslidis
Dr. Anastasios (Tasos) Aslidis
Independent Director
Independent Director
55.00K
-9.09%
Mr. Suhel Bhutawala
Mr. Suhel Bhutawala
Independent Director
Independent Director
50.00K
+10.00%

よくある質問

Cosmos Health Incの䞊䜍5名の株䞻は誰ですか


Cosmos Health Incの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Grigorios Siokas

Cosmos Health IncCOSMの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Cosmos Health Incの株匏を保有しおいる機関は39瀟あり、保有株匏の総垂堎䟡倀は玄1.44Mで、党䜓の2.84%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-1819231.00増加しおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。